project id: TCGA-READ; case submitter id: TCGA-AF-6136; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; age at index: 72; days to birth: -26490; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1939; age at diagnosis: 26490; ajcc pathologic m: MX; ajcc pathologic n: N1b; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 741.0; icd 10 code: C19; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Rectosigmoid junction; synchronous malignancy: No; tissue or organ of origin: Rectosigmoid junction; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.6; longest dimension: 1.0; oct embedded: No; shortest dimension: 0.5; portion submitter id: TCGA-AF-6136-01A-11; percent lymphocyte infiltration: 15.0; percent monocyte infiltration: 0.0; percent necrosis: 1.0; percent neutrophil infiltration: 5.0; percent stromal cells: 0.0; percent tumor nuclei: 75.0;